UrgoStart is a type of interactive wound dressing. Clinical trial evidence shows that using UrgoStart to treat diabetic foot ulcers increases wound healing compared with non-interactive dressings. For venous leg ulcers, the evidence shows that UrgoStart increases the rate of wound healing in the short term compared with non-interactive dressings when used with standard care, but the impact on complete wound healing is less certain. There is much less evidence for non-venous leg ulcers so, although clinical and patient benefits are plausible, there is no positive recommendation about UrgoStart in this patient group. Cost analyses suggest that using UrgoStart as part of the overall management of diabetic foot ulcers and venous leg ulcers could save costs for the NHS.